Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Norbert W. Bischofberger, PhD
Age : 61
Public asset : 188,355,863 USD
Linked companies : Gilead Sciences, Inc.
Summary 
Dr. Norbert W. Bischofberger is Chief Scientific Officer & Executive VP-Research at Gilead Sciences, Inc.

He is on the Board of Directors at InCarda Therapeutics, Inc. Dr. Bischofberger was previously employed as Senior Scientist-DNA Synthesis Group by Genentech, Inc.

He received his undergraduate degree from the University of Innsbruck and a doctorate degree from Swiss Federal Institute of Technology.


Current positions of Norbert W. Bischofberger, PhD 
NameTitle Since
Gilead Sciences, Inc.
(Biotechnology & Medical Research)
Chief Scientific Officer & Executive VP-Research 1990
InCarda Therapeutics, Inc. Director 2016


Holdings of Norbert W. Bischofberger, PhD 
NameEquities%Valuation
Gilead Sciences (GILD)
Biotechnology & Medical Research
2,324,8070.18%188,355,863 USD


Norbert W. Bischofberger, PhD: Personal Network 


Most Read News 
10/17DJSUMNER REDSTONE : Redstone's Ex-Companion Sues His Daughter, Grandson
04:11a WILLIAM ACKMAN : Ackman urges ADP to consider acquiring Ceridian amid proxy fight
10/19 DAVID HENRY : U.S. bankers hold onto hopes that Trump will boost profits
10/17 FRANCK RIBOUD : Riboud to stand down as Danone chairman - Le Monde
10/13 DAVID HENRY : JPMorgan's card gamble lures millennial travelers, squeezes competitors
10/17DJRONNIE LETEN : Investor Net Asset Value Rises 1.4% on Quarter in Third Quarter
10/16DJJACK MA : China's Xi Approaches a New Term With a Souring Taste for Markets
10/19 IGOR SECHIN : Rosneft's Sechin says no watershed in oil market, U.S. shale oil a risk
10/17DJWARREN BUFFETT : Top Company News of the Day
10/18 RICHARD BRANSON : Billionaire Branson targeted in $5 million scam 'straight out of le Carre'
More news


© 2017 People and Ownership :   
Advertisement
Norbert W. Bischofberger, PhD : Connections 
CGI Pharmaceuticals, Inc.
American Chemical Society
Gladstone Foundation (CA)
InCarda Therapeutics, Inc.
Asset Management Ventures LLC
Institute for Systems Biology
The Aids Institute, Inc.
Gilead Foundation
University of Southern California
Collidion, Inc. (California)
University of Rochester
California Biomedical Innovation Alliance
Biotechnology Innovation Organization
Ralph M. Parsons Foundation
Ohio Wesleyan University



Popular Business Leaders 
William Ackman Jean-paul Agon Liliane Bettencourt Jeff Bezos Vincent Bolloré Richard Branson John Bryant Warren Buffett Kenneth Chenault Gary Cohn Tim Cook Jean Coutu Jamie Dimon Ralph Dommermuth John Edwards Douglas Flint Kenneth Frazier Bill Gates Carlos Ghosn Mario Greco Stuart Gulliver David Henry Carl Icahn Joseph Jimenez Dara Khosrowshahi Daniel Loeb Jack Ma James Murdoch Elon Musk Michael O'leary Nelson Peltz Wolfgang Porsche Thomas Rabe Sumner Redstone Franck Riboud Alexandre Ricard Xavier Rolet Wilbur Ross Sheryl Sandberg Charles Schwab Vishal Sikka Carlos Slim George Soros Ulrich Spiesshofer Rupert Stadler Johannes Teyssen John Watson Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders